ORIGINAL RESEARCH

Immune responses associated with Hodgkin lymphoma

Patrakeeva VP, Dobrodeeva LK
About authors

N. Laverov Federal Center for Integrated Arctic Research, Ural Branch of the Russian Academy of Sciences, Arkhangelsk, Russia

Correspondence should be addressed: Veronika P. Patrakeeva
Nikolsky prospect, 20, Arkhangelsk, 163020, Russia; ur.xednay@akinorev.aweekartap

About paper

Funding: the study was performed as part of the Program of Fundamental Scientific Research on the topic of the environmental immunology laboratory, Institute of Physiology of Natural Adaptations, Laverov Federal Center for Integrated Arctic Research, Ural Branch of the Russian Academy of Sciences (project №122011300377-5).

Author contribution: Dobrodeeva LK — study planning, data acquisition, processing and interpretation, literature review, manuscript writing; Patrakeeva VP — data processing, literature review, manuscript writing.

Compliance with ethical standards: the study was approved by the Ethics Committee of the Laverov Federal Center for Integrated Arctic Research, the Ural branch of RAS (protocol № 4 of 7 December 2016, protocol No. 6 of 14 February 2022) and conducted in accordance with the principles of the Declaration of Helsinki (1975, rev. 2013).

Received: 2023-04-07 Accepted: 2023-06-04 Published online: 2023-06-21
|
  1. Hoffman R, Benz EJ, Silberstein LE, Heslop HE, Weitz JI, Anastasi J, et al, editors. Hematology: basic principles and practice. Elsevier, Philadelphia, 2017; p. 130.
  2. Liu Y, Abdul Razak FR, Terpstra M, et al. The mutational landscape of Hodgkin lymphoma cell lines determined by whole-exome sequencing. Leukemia. 2014; 28: 2248–51.
  3. Ramazanova RD, Ratobolskix AV. Rol' virusa Ehpshtejna–Barr v patogeneze limfomy xodzhkina u detej. Universitetskaya medicina Urala. 2021; 7–3 (26): 34–35. Russian.
  4. Ship MA, Stefano GB, Switzer SN, Griffin JD, Reinherz EL. CD10(CALLA)/neutral endopeptidase modulates inflammatory peptide-induced changes in neutrophil morphology, migration, and adhesion proteins and is itself regulated by neutrophil activation. Blood. 1991; 78: 1834–41.
  5. Hirashima M, Higuchi S, Sakamoto K, Nishiyama T, Okada H. The ratio of neutrophils to lymphocytes and the phenotypes of neutrophils in patient with early gastric cancer. Journal of Cancer Research and Clinical Oncology. 1997; 124 (6): 329–34. DOI: 10.1007/s004320050178.
  6. Marini O, Costa S, Bevilacqua D. Mature CD10+ and immature CD10− neutrophils present in G-CSF–treated donors display opposite effects on T cells. Blood. 2017; 129 (10): 1343–56. DOI: 10.1182/blood-2016-04-713206.
  7. Ding L, Vezzani B, Khan N, Su J, Xu L, Yan G, et al. CD10 expression identifies a subset of human perivascular progenitor cells with high proliferation and calcification potentials. Stem Cells. 2020; 38 (2): 261–75. DOI: 10.1002/stem.3112.
  8. Huang X, He C, Lin G, Lu L, Xing K, Hua X, et al. Induced CD10 expression during monocyte-to-macrophage differentiation identifies a unique subset of macrophages in pancreatic ductal denocarcinoma. Biochemical and Biophysical Research Communications. 2020; 524 (4): 1064–71. DOI: 10.1016/j.bbrc.2020.02.042.
  9. Kassirskij IA, Alekseev GA. Klinicheskaya gematologiya. M.: Medicina, 1970; 328 s. Russian.
  10. Fajnshejn FEh. Aplasticheskie i gipoplasticheskie anemii. M.: Medicina,1965; 215 s. Russian.
  11. Juutilainen A, Hämäläinen S, Niemenpää J, Kuittinen T, Pulkki K, Koivula I, et al. Serum cortisol and inflammatory response in neutropenic fever. Annals of Hematology. 2011; 90 (12): 1467–75. DOI: 10.1007/s00277-011-1211-6.
  12. Zierath D, Tanzi P, Shibata D, Becker KJ. Cortisol is More Important than Metanephrines in Driving Changes in Leukocyte Counts after Stroke. Journal of Stroke & Cerebrovascular Diseases. 2018; 27 (3): 555–62. DOI: 10.1016/j.jstrokecerebrovasdis.2017.09.048.
  13. Bagby GC, Gabourel JD, Linman JW. Glucocorticoid therapy in the preleukemic syndrome. Annals of Internal Medicine. 1980; 92: 241–248.
  14. Golde D, Cline M. Hormonal interactions with hemopoietin cells in vitro. Transplantation Proceedings. 1978; 10: 95–97.
  15. Wright DG, Fanci AS, Dale DC. Correction of human cyclic neutropenia with prednisolone. The New England Journal of Medicine. 1978; 298: 295–300.
  16. Lightman SL, Birnie MT, Conway-Campbell BL. Dynamics of ACTH and cortisol secretion and implications for disease. Endocrine Reviews. 2021; 41: 470–490. DOI: 10.1210/ENDREV/ BNAA002.
  17. Nexaev SG, Grigorev SG. Polimorfnoyadernye lejkocity kak sistema antiehndotoksikacionnoj zashhity organizma. Immunologiya. 2010; 31 (3): 116–8. Russian.
  18. Cascao R, Rosario HS, Fonseca JE. Neutrophils: Warriors and commanders in immune mediated inflammatory diseases. Acta reumatologica portuguesa. 2009; 34 (2B): 313–26.
  19. Нen Y, Wu H, Winnall WR, Loveland KL. Tumor necrosis factor-a stimulates human neutrophyls to release preformed activin. Immunology and Cell Biology. 2011; 89 (8): 889–96.
  20. Hedrick CC, Malanchi I. Neutrophils in cancer: heterogeneous and multifaceted. Nature Reviews Immunology. 2021; 22 (3): 1–15. DOI: 10.1038/s41577-021-00571-6.
  21. Kenny EF, Herzig A, Krüger R, Muth A, Mondal S, Thompson PR, et al. Diverse stimuli engage different neutrophil extracellular trap pathways. Elife. 2017; 6: e24437. DOI: 10.7554/eLife.24437.
  22. Jorch SK, Kubes P. An emerging role for neutrophil extracellular traps in noninfectious disease. Nature Medicine. 2017; 23: 279– 87. DOI: 10.1038/nm.4294.
  23. Huizinga TW, van der Schoot CE, Roos D, Weening RS. Induction of neutrophil Fc-gamma receptor I expression can be used as a marker for biological activity of recombinant interferon-gamma in vivo. Blood. 1991; 77: 2088–90.
  24. Kakinoki Y, Kubota H, Yamamoto Y. CD64 surface expression on neutrophils and monocytes is significantly up-regulated after stimulation with granulocyte colony-stimulating factor during CHOP chemotherapy for patients with non-Hodgkins lymphoma. International Journal of Hematology. 2004; 79 (1): 55–62.
  25. Kerst JM, van der Winkel JG, Evanse AH. Granulocyte colonystimulating factor induces FcγRI(CD64) positive geutrophils via an effect on myeloidprecursor cells. Blood. 1993; 81: 1457–64.
  26. Gasparoto TH, Dalboni TM, Amôr NG, Abe AE, Perri G, Lara VS, et al. Fcγ receptors on aging neutrophils. Journal of Applied Oral Science. 2021; 29: e20200770. DOI: 10.1590/1678-7757-20200770.
  27. Dang Y, Lou J, Yan Y. The role of the neutrophil Fcγ receptor I (CD64) index in diagnosing spontaneous bacterial peritonitis in cirrhotic patients. International Journal of Infectious Diseases. 2016; 49: 154–60
  28. Ambruso DR, Ellison M, Briones N. Effects of Interferon-Gamma 1-b (IFN-γ) on Neutrophil Function and Biochemistry in Patients with Chronic Granulomatous Disease. Blood. 2018; 132 (Supp. 1): 2400. DOI: 10.1182/blood-2018-99-115683.
  29. Nesterova IV, Chudidova GA, Lomtatidze LV, Kovaleva LV, Sapun OI. Fenotipicheskie xarakteristiki subpopulyacij monocitov CD64+CD16–CD32+CD11B+, CD64+CD16+CD32+CD11B+, CD64–CD16+ CD11B+ pri vrozhdennoj pnevmonii u gluboko nedonoshennyx novorozhdennyx. Immunologiya. 2014; 35 (1): 33–37. Russian.
  30. Aguilar-Ruiz SR, Torres-Aguilar H, Gonzalez-Dominguez E, Narvaez J, Gonzalez-Perez G, Vargas-Avala G, et al. Human CD16+ and CD16- monocyte subsets display unique effector properties in inflammatory conditions in vivo. Journal of Leukocyte Biology. 2011; 90 (6): 1119–31. DOI: 10.1189/jlb.0111022.
  31. Barclay AN, Brown MH, Law SK. The leukocyte antigen factsbook. Academic Press. 1997; p. 192–193.
  32. Belg KU, Dayyani E, Horelt A, Siedlar M, Frankenberger M, Frankenberger B, et al. The protein-flammatory -CD14+CD16+DR- monocytes are a major source of TNF. Journal of Immunology. 2002; 168 (7): 3536–42. DOI: 10.4049/jimmunol.168.7.3536.
  33. Kapellos TS, Bonaguro L, Gemünd I, Reusch N, Saglam A, Hinkley ER, et al. Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases. Frontiers of Immunology. 2019; 10: 2035. DOI: 10.3389/fimmu.2019.02035.
  34. Sanchez-Torres C, Garcia-Roto GS, Cornejo-Cortes MA, RivasCarvalho A, Sanchez-schmitz G. CD16+ and CD16+- human blood monocyte subsets differentiate in vitro to dendritic cells with different abilities to stimulate CD4T-cells. International Immunology. 2001; 13: 1571–81. DOI: 10.1093/intimm/13.12.1571.
  35. De Maeyer RPH, Chambers ES. The impact of ageing on monocytes and macrophages. Immunology Letters. 2021; 230: 1–10. DOI: 10.1016/j.imlet.2020.12.003.
  36. Ziegler-Heitbrock L, Ancuta P, Crow S, Dalod M, Grau V, Hart DN. Nomenclature of monocytes and dendritic cells in blood. Blood. 2010; 116 (16): 74–80.
  37. Gasparoto TH, Dalboni TM, Amôr NG, Abe AE, Perri G, Lara VS, et al. Fcγ receptors on aging neutrophils. Journal of Applied Oral Science. 2021; 29: e20200770. DOI: 10.1590/1678-7757-20200770.
  38. Kozinec GI, Terenteva GI, Fajnshtejn FEh, Shishkonov EhG, Lulcina SM, Yarustovskaya LEh, Lipac AA. Morfologicheskaya i funkcional'naya xarakteristika kletok kostnogo mozga i krovi. V kn.: Normal'noe krovetvorenie i ego regulyaciya. M.: Medicina, 1976; c. 98–155. Russian.
  39. Chelovek: mediko-biologicheskie dannye: doklad rabochej gruppy Komiteta II MKRZ po uslovnomu cheloveku. Per. s angl. M.: Medicina, 1977; 496 s. Russian.
  40. Miller JFAP. The function of the thymus and its impact on modern medicine. Science. 2020; 31: 369 (6503): eaba2429. DOI: 10.1126/science.aba2429.
  41. Egorov ES, Merzlyak EM, Shelenkov AA, Britanova OV, Sharonov GV, Staroverov DB, et al. Quantitative profiling of immune repertoires for minor lymphocyte counts using unique molecular identifiers. Journal of Immunology. 2015; 194 (12): 6155–63. DOI: 10.4049/ jimmunol.1500215.
  42. Aldinucci D, Gloghini A, Pinto A, De Filippi R, Carbone A. The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape. J Pathol. 2010; 221 (3): 248–63.
  43. Carbone A, Gloghini A, Castagna L, Santoro A, Carlo-Stella C. Primary refractory and early-relapsed Hodgkin's lymphoma: strategies for therapeutic targeting based on the tumour microenvironment. J Pathol. 2015; 237 (1); 4–13.
  44. Bachanova V, Hegerova L, Cao Q, Janakiram M, Maakaron J, Ayyappan S, et al. Ruxolitinib plus nivolumab in patients with R/R Hodgkin lymphoma after failure of check-point inhibitors: Preliminary Report on Safety and Efficacy. Blood. 2021; 138 (1): 230.
  45. Zhao P, Xie L, Yu L, Wang P. Targeting CD47-SIRPα axis for Hodgkin and non-Hodgkin lymphoma immunotherapy. Genes & Diseases. 2023; 100070.
  46. Elenkov IJ, Chrousos GP. Stress-system — organization, physiology and immunoregulation. Neuroimmunomodulation. 2006; 13 (5–6): 257–67. DOI: 10.1159/000104853.
  47. Antoni MH, Dhabhar FS. The impact of psychosocial stress and stress management on immune responses in patients with cancer. Cancer. 2019; 125 (9): 1417–31. DOI: 10.1002/cncr.31943.
  48. Pulopulos MM, Baeken C, De Raedt R. Cortisol response to stress: The role of expectancy and anticipatory stress regulation. Hormones and Behavior. 2020; 117: 104587. DOI: 10.1016/j.yhbeh.2019.104587.
  49. Balkwill F. TNF-alpha in promotion and progression of cancer. Cancer and Metastasis Reviews. 2006; 25 (3): 409–16. DOI: 10.1007/s10555-006-9005-3.